Story
Celanese Options Market Prices in 10% Swing on Upcoming Earnings

Celanese Corp. (NYSE:CE) shares could experience a significant price swing of approximately 10% following the company's upcoming earnings announcement on November 2, according to an analysis of options market data compiled by Bloomberg.
Options Pricing and Historical Volatility
The implied move is derived from the pricing of options contracts and reflects traders' expectations for stock volatility after a specific catalyst, such as an earnings release. It is a measure of potential magnitude, not a prediction of the direction of the move.
An examination of Celanese's past eight earnings reports shows a mixed record of actual stock performance versus options-implied volatility. The stock's post-earnings move has exceeded the market's expectation in four of the last eight instances, suggesting a history of surprising investors.
A Look at Past Earnings Reactions
AdIn its two most recent earnings reports, Celanese stock moved less than anticipated. Following its August 4 report, shares declined 2.8% against an implied move of 8.2%. Similarly, on May 5, the stock fell 4.6% when options had priced in an 11.8% swing.
However, the company has also seen reactions that were far more dramatic than expected. A review of prior announcements reveals several instances where the actual move surpassed the implied volatility:
- A 15.1% drop versus an 11.2% implied move.
- A 12.7% gain compared to a 12.3% implied move.
- An 18.0% decline when a 10.0% move was expected.
- The largest divergence occurred when shares plummeted 29.4% on an earnings release where options had only priced in a 4.8% move.
Celanese, a global chemical and specialty materials company, is scheduled to release its financial results after the market closes on Thursday, November 2.
Read next
More on Stocks
NVIDIA Stock Rallies on Strong AI Demand Signals from SpaceX, Morgan Stanley
Shares of the chipmaker gained over 3% following reports of a $40 billion GPU procurement plan by SpaceX and a bullish note from Morgan Stanley highlighting increased data center demand.

Nanobiotix Shares Rise on Positive Phase 1 Melanoma Trial Data
Nanobiotix (NASDAQ: NBTX) stock gained after the company reported promising final data from a Phase 1 trial of its cancer therapy, JNJ-1900, which showed a 41.7% overall response rate in patients with advanced, treatment-resistant melanoma.

Moroccan All Shares Index Edges Up 0.14% on Sector Strength
The Casablanca stock market closed slightly higher on Monday, with the benchmark Moroccan All Shares index gaining 0.14% amid strength in the banking and beverage sectors, despite a majority of stocks declining.

Petrobras CEO Dismisses Post-Election Stock Plunge as 'Speculative'
Petrobras CEO Magda Chambriard labeled the nearly 10% drop in the company's shares following President Lula's reelection as a 'speculative move,' asserting the state-run oil firm's fundamentals remain strong.